open access

Vol 13, No 5 (2018)
Case Reports
Published online: 2018-09-13
Get Citation

Challenging diagnostic and therapeutic problems in a high-risk patient with mixed aortic valve disease and atrial tachycardia.

Patrycja Anna Lebioda, Katarzyna Piestrzeniewicz, Jarosław Drożdż
DOI: 10.5603/FC.a2018.0089
·
Folia Cardiologica 2018;13(5):450-452.

open access

Vol 13, No 5 (2018)
Case Reports
Published online: 2018-09-13

Abstract

The study is a case of a 80-year-old female with multiple comorbidities, mixed aortic valve disease and heart failure decompensation in the course of atrial tachycardia. The introduced treatment with beta-blockers and subsequent heart rate reduction resulted in negative hemodynamic response as shown by elevation of biochemical markers of renal and liver failure. This observation together with clinical presentation indicated pathophysiology of aortic regurgitation (AR) as the cause of this phenomenon. This report shows the significance of clinical features in determining severity of AR and complex attitude in therapeutic decision making process in a high-risk patient.

Abstract

The study is a case of a 80-year-old female with multiple comorbidities, mixed aortic valve disease and heart failure decompensation in the course of atrial tachycardia. The introduced treatment with beta-blockers and subsequent heart rate reduction resulted in negative hemodynamic response as shown by elevation of biochemical markers of renal and liver failure. This observation together with clinical presentation indicated pathophysiology of aortic regurgitation (AR) as the cause of this phenomenon. This report shows the significance of clinical features in determining severity of AR and complex attitude in therapeutic decision making process in a high-risk patient.
Get Citation

Keywords

mixed aortic valve disease, atrial tachycardia, high-risk patient

About this article
Title

Challenging diagnostic and therapeutic problems in a high-risk patient with mixed aortic valve disease and atrial tachycardia.

Journal

Folia Cardiologica

Issue

Vol 13, No 5 (2018)

Pages

450-452

Published online

2018-09-13

DOI

10.5603/FC.a2018.0089

Bibliographic record

Folia Cardiologica 2018;13(5):450-452.

Keywords

mixed aortic valve disease
atrial tachycardia
high-risk patient

Authors

Patrycja Anna Lebioda
Katarzyna Piestrzeniewicz
Jarosław Drożdż

References (4)
  1. Sampat U, Varadarajan P, Turk R, et al. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol. 2009; 54(5): 452–457.
  2. Roberts PA, Lin ACW, Cowan BR, et al. Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation. Int J Cardiovasc Imaging. 2018; 34(4): 615–624.
  3. Evangelista A, Tornos P, Sambola A, et al. Role of vasodilators in regurgitant valve disease. Curr Treat Options Cardiovasc Med. 2006; 8(6): 428–434.
  4. Nishimura RA, Otto C, Bonow R, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2014; 129(23).

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl